BMEA
Price
$1.37
Change
+$0.01 (+0.74%)
Updated
Aug 21 closing price
Capitalization
99.3M
72 days until earnings call
Intraday BUY SELL Signals
CAI
Price
$26.27
Change
+$1.69 (+6.88%)
Updated
Aug 21 closing price
Capitalization
7.42B
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs CAI

BMEA vs CAI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BMEA vs. CAI commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and CAI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (BMEA: $1.37 vs. CAI: $26.27)
Brand notoriety: BMEA and CAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 81% vs. CAI: 130%
Market capitalization -- BMEA: $99.3M vs. CAI: $7.42B
BMEA [@Biotechnology] is valued at $99.3M. CAI’s [@Biotechnology] market capitalization is $7.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileCAI’s FA Score has 2 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • CAI’s FA Score: 2 green, 3 red.
According to our system of comparison, CAI is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while CAI’s TA Score has 6 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 5 bearish.
  • CAI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CAI is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а +3.79% price change this week, while CAI (@Biotechnology) price change was +20.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

BMEA is expected to report earnings on Nov 03, 2026.

CAI is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($7.42B) has a higher market cap than BMEA($99.3M). BMEA YTD gains are higher at: 10.484 vs. CAI (-2.632). CAI has higher annual earnings (EBITDA): 111M vs. BMEA (-63.38M). CAI has more cash in the bank: 823M vs. BMEA (44.7M). BMEA has less debt than CAI: BMEA (1.24M) vs CAI (431M). CAI has higher revenues than BMEA: CAI (907M) vs BMEA (0).
BMEACAIBMEA / CAI
Capitalization99.3M7.42B1%
EBITDA-63.38M111M-57%
Gain YTD10.484-2.632-398%
P/E RatioN/A2.74-
Revenue0907M-
Total Cash44.7M823M5%
Total Debt1.24M431M0%
FUNDAMENTALS RATINGS
CAI: Fundamental Ratings
CAI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEACAI
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
56%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
9%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
8%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 6 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
50%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
CAI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPAY4.010.15
+3.89%
Repay Holdings Corp
AVAV160.220.43
+0.27%
AeroVironment
BACCU10.81N/A
N/A
Blue Acquisition Corp
PIII10.31-0.03
-0.29%
P3 Health Partners Inc
VSTS12.69-0.13
-1.01%
Vestis Corp

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with CLRB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+0.74%
CLRB - BMEA
38%
Loosely correlated
N/A
CAI - BMEA
38%
Loosely correlated
+6.88%
HUMA - BMEA
37%
Loosely correlated
-5.75%
PROK - BMEA
36%
Loosely correlated
+13.38%
ACET - BMEA
36%
Loosely correlated
-2.03%
More

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
+6.88%
BMEA - CAI
38%
Loosely correlated
+0.74%
TECH - CAI
34%
Loosely correlated
+0.06%
RXRX - CAI
33%
Loosely correlated
+4.79%
BNTC - CAI
32%
Poorly correlated
+3.61%
ABCL - CAI
30%
Poorly correlated
-2.16%
More